OVERVIEW

The market for HIV diagnosis is projected to reach USD 8.33 billion by 2026, with a CAGR of 8.1 percent from 2021 to 2026. Market growth is expected to be driven by factors such as the increasing global prevalence of HIV/AIDS, the rising number of blood transfusions and blood donations, the benefits offered by point-of-care devices and kits, and increased policy measures. The impact of the COVID-19 outbreak on the industry will be thoroughly evaluated in the following report. The study also contrasts the pre-COVID-19 and post-COVID-19 markets.

TABLE OF CONTENT

• 1 Global HIV Diagnosis Market
  • 1.1 Study Objectives
  • 1.2 Market Definition
  • 1.3 Study Scope
    • 1.3.1 Markets Covered
    • 1.3.2 Geographic Scope

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global HIV Diagnosis Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global HIV Diagnosis Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global HIV Diagnosis Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global HIV Diagnosis Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global HIV Diagnosis Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global HIV Diagnosis Market ? By Product (Market Size ? & million/billion)
  • 8.1 Consumables
  • 8.2 Instruments
  • 8.3 Software & Services

• 9 Global HIV Diagnosis Market - By Test Type
  • 9.1 Antibody Tests
  • 9.2 Viral Load Tests
  • 9.3 CD4 Tests
  • 9.4 Tests for Early Infant Diagnosis
  • 9.5 Tests for Viral Identification

• 10 Global HIV Diagnosis Market - By End-User
  • 10.1 Diagnostic Laboratories
  • 10.2 Hospitals
  • 10.3 Blood Banks
  • 10.4 Home Care Settings
  • 10.5 Other

• 11 Global HIV Diagnosis Market ? By Geography (Market Size ? & million/billion)
  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 U.K
    • 11.3.2 Germany
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Rest of APAC
  • 11.5 Rest of the World
    • 11.5.1 South America
    • 11.5.2 Middle East
    • 11.5.3 Africa

• 12 Global HIV Diagnosis Market ? Entropy
  • 12.1 New product launches
  • 12.2 M&A's, collaborations, JVs and partnerships

• 13 Global HIV Diagnosis Market Company Profile (Key Players)
  • 13.1 Market Share, Company Revenue, Products, M&A, Developments
  • 13.2 Siemens Healthineers (A Division of Siemens AG)
  • 13.3 Roche Diagnostics (Division of Hoffman La Roche Ltd.)
  • 13.4 Merck KGaA
  • 13.5 Becton, Dickinson & Company
  • 13.6 Abbott Laboratories
  • 13.7 Bio-Rad Laboratories
  • 13.8 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • 13.9 Thermo-Fisher Scientific Inc.
  • 13.10 Hologic Inc.
  • 13.11 Alere Inc.
  • 13.12 Company 11 & more

• 14 Global HIV Diagnosis Market - Appendix
  • 14.1 Sources
  • 14.2 Abbreviations